桂林三金药业股份有限公司 2025年第三季度报告

Core Viewpoint - The company, Guilin Sanjin Pharmaceutical Co., Ltd., has released its third-quarter financial report for 2025, ensuring the accuracy and completeness of the information disclosed, with no significant omissions or misleading statements [1][2]. Financial Data Summary - The third-quarter financial report has not been audited [4]. - The company confirms that there are no adjustments or restatements required for previous accounting data [3]. - There are no non-recurring profit and loss items applicable for the reporting period [3]. Shareholder Information - The report includes details on the total number of common shareholders and the top ten shareholders, although specific numbers are not provided in the document [3]. - There are no changes in the participation of major shareholders in the securities lending business compared to the previous period [4]. Other Important Matters - The company has not indicated any other significant matters that require disclosure in this report [4].